Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIODESIX INCBDSX · Entity 6053 | Chief Development Officer | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIODESIX INC
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,359 |
Ending reported balance
After 2026-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-20 · Exercise / conversion · Acquired 1,528 · Balance 10,915 F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Row 2 · 2026-02-23 · Sale · Disposed 556 · Balance 10,359 F2: These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs. F3: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,582 |
Reported balance
After 2026-02-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-20 · Exercise / conversion · Disposed 1,528 · Balance 4,582 F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4: These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025. F5: These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2: These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F3: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
F5: These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionStock Options (Right to buy) · Derivative | 13,206 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · derivative · entry 15 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,640 Underlying: Common Stock · 13,206 shares Expires 2027-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests in 60 successive, equal monthly installments measured from January 1, 2017. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionStock Options (Right to buy) · Derivative | 1,903 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · derivative · entry 14 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,903 shares Expires 2026-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionStock Options (Right to buy) · Derivative | 6,191 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · derivative · entry 13 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,191 shares Expires 2026-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionStock Options (Right to buy) · Derivative | 24,848 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · derivative · entry 12 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421 Underlying: Common Stock · 24,848 shares Expires 2026-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests in 60 successive, equal monthly installments measured from January 1, 2016. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionStock Options (Right to buy) · Derivative | 5,053 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · derivative · entry 11 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,053 shares Expires 2025-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vested in 60 successive, equal monthly installments measured from January 1, 2015. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionStock Options (Right to buy) · Derivative | 3,369 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · derivative · entry 10 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,369 shares Expires 2022-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option vested 40% on March 19, 2014, and the remaining 60% in 36 successive, equal monthly installments measured from March 19, 2014. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 4,327 | $0.78 | $3,375.06 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 9 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 10,984 | $0.78 | $8,567.52 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 8 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 12,285 | $0.42 | $5,159.70 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 7 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 13,206 | $0.42 | $5,546.52 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 6 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 1,903 | $0.84 | $1,598.52 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 5 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 6,191 | $0.84 | $5,200.44 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 4 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 24,848 | $0.84 | $20,872.32 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 3 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 5,053 | $4.40 | $22,233.20 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 2 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 21:15 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 3,369 | $3.33 | $11,218.77 |
DisclosureSEC source: 0001140361-20-029017 · form4.xml · nonDerivative · entry 1 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.